US Broker Ratings

Tyra Biosciences, Inc. (TYRA) Stock Analysis: 124% Potential Upside Ignites Investor Interest

Tyra Biosciences, Inc. (NASDAQ: TYRA), a promising clinical-stage biotechnology company situated in the healthcare sector, has captured the attention of investors with an impressive potential upside of 124.09%. This burgeoning..

Kura Oncology, Inc. (KURA) Investor Outlook: Analysts Eye a 165% Upside Potential

Kura Oncology, Inc. (KURA) is gaining traction among investors, buoyed by an impressive potential upside of 165.75% as derived from current analyst ratings. This biopharmaceutical company, headquartered in San Diego,..

Auna SA (AUNA) Stock Analysis: Exploring a Promising 118.51% Potential Upside

Auna S.A. (AUNA), a significant player in the healthcare sector, is capturing investor attention with its impressive potential upside of 118.51%. As a healthcare service provider operating hospitals and clinics..

Cronos Group Inc. (CRON) Stock Analysis: Can This Cannabis Player Overcome a -17.12% Potential Downside?

Cronos Group Inc. (NASDAQ: CRON), a prominent player in the cannabinoid sector, has captured the attention of investors with its diverse product line that includes dried flowers, pre-rolls, oils, and..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: A Biotech Gem with 125% Upside Potential

Enliven Therapeutics, Inc. (NASDAQ: ELVN), a promising player in the biotechnology sector, is making waves with its innovative approach to cancer treatment. With a market capitalization of $1.08 billion and..

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: A 146% Upside Beckons in the Biotech Frontier

For individual investors with a penchant for the biotechnology sector, Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) presents a compelling investment opportunity. With a potential upside of 146.39% based on analyst target..

Orthofix Medical Inc. (OFIX) Investor Outlook: Analyzing a Potential 53.61% Upside in the Healthcare Sector

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the healthcare sector, specifically within the medical devices industry, is capturing investor attention with its substantial potential upside of 53.61%. With..

Avanos Medical, Inc. (AVNS) Stock Analysis: Understanding the Healthcare Innovator’s Future Prospects

Avanos Medical, Inc. (NASDAQ: AVNS), a prominent player in the medical devices industry, is making waves with its innovative healthcare solutions. With a market capitalization of $518.78 million, the company..

Bicycle Therapeutics (BCYC) Stock Analysis: Exploring a 226.85% Upside Potential

For investors keen on the biotechnology sector, Bicycle Therapeutics plc (NASDAQ: BCYC) is currently presenting a fascinating opportunity. This UK-based clinical-stage pharmaceutical company is making waves with its innovative approach..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating Growth in Healthcare with a 2.46% Upside

As the healthcare sector continues to evolve, InnovAge Holding Corp. (INNV), a key player in the medical care facilities industry, is carving out its niche with its unique approach to..

Amylyx Pharmaceuticals, Inc. (AMLX) Investor Outlook: A 56.95% Potential Upside in Biotech Exploration

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) stands as a compelling consideration for investors eager to tap into the innovative landscape of biotechnology. With a market capitalization of $1.33 billion, this clinical-stage..

RxSight, Inc. (RXST) Stock Analysis: Navigating the Healthcare Sector with Innovative Medical Devices

RxSight, Inc. (NASDAQ: RXST) stands at the intersection of cutting-edge technology and medical innovation, offering investors a unique stake in the rapidly evolving healthcare sector. With a market capitalization of..

Vir Biotechnology, Inc. (VIR) Investor Outlook: Unpacking a Potential 236% Upside Amidst Challenging Financials

Investors with a taste for high-risk, high-reward opportunities may find Vir Biotechnology, Inc. (NASDAQ: VIR) an intriguing prospect. This clinical-stage biopharmaceutical company, headquartered in San Francisco, is dedicated to discovering..

LENZ Therapeutics, Inc. (LENZ): Investor Outlook on a Biotech Stock with 136% Potential Upside

LENZ Therapeutics, Inc. (NASDAQ: LENZ), a promising player in the biotechnology sector, has captured investor attention with its focus on developing innovative therapies to enhance vision. With a market capitalization..

Butterfly Network, Inc. (BFLY) Stock Analysis: Unveiling a 40.74% Potential Upside in the Medical Devices Sector

Butterfly Network, Inc. (NASDAQ: BFLY), a prominent player in the healthcare sector, specifically in medical devices, is capturing investor attention with its innovative range of ultrasound imaging solutions. Headquartered in..

Simulations Plus, Inc. (SLP) Investor Outlook: Analyzing a 29.87% Potential Upside in Healthcare Innovation

Simulations Plus, Inc. (NASDAQ: SLP) is carving out a noteworthy niche in the healthcare sector by providing cutting-edge software solutions for drug discovery and development. Headquartered in Research Triangle Park,..

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: Exploring a 56.74% Potential Upside in the Rare Disease Market

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) stands out in the healthcare sector, particularly within the niche of specialty and generic drug manufacturing. The Deer Park, Illinois-based company has carved a unique..

Valneva SE (VALN) Stock Analysis: A 49% Potential Upside in the Biotech Vaccine Space

Valneva SE (VALN), a France-based biotechnology company, is emerging as a notable player in the healthcare sector with a market cap of $789.9 million. Specializing in the development and commercialization..

Gyre Therapeutics, Inc. (GYRE) Investor Outlook: Exploring a 145% Potential Upside in the Biotech Sector

Gyre Therapeutics, Inc. (GYRE) is capturing the attention of investors in the biotechnology sector with its bold approach to tackling organ fibrosis through innovative pharmaceutical solutions. Headquartered in San Diego,..

CeriBell, Inc. (CBLL) Stock Report: A Potential 145.92% Upside in Healthcare Innovation

For investors seeking exposure in the healthcare sector, CeriBell, Inc. (NASDAQ: CBLL) presents an intriguing opportunity. This medical technology company, headquartered in Sunnyvale, California, is making strides in the realm..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds